Sanara MedTech Inc. - Common Stock (SMTI)

SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc (“Sanara”) (Nasdaq:SMTI). In tandem, Sanara agreed to make a minority investment in cash for equity in BMI.

Sanara MedTech Inc. (NASDAQSMTI) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 3.2% on the day to $41.27.

FORT WORTH, TX, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQSMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Zach Fleming, the Company’s Chief Executive Officer, will present at the Piper Sandler 34th Annual Healthcare Conference in New York, New York on Wednesday, November 30, 2022 at 12:30 p.m. ET and will participate in a panel discussion at the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference in Miami, Florida on Thursday, December 8, 2022 at 2:45 p.m. ET.

FORT WORTH, TX, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQSMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter ended September 30, 2022.

FORT WORTH, TX, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQSMTI) and InfuSystem Holdings, Inc. (“InfuSystem”) (NYSE American: INFU) announced today the establishment of a partnership, SI Wound Care, LLC (“SI Wound Care”), focused on delivering a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction. The partnership is expected to enable InfuSystem to offer innovative products including Cork Medical, LLC’s (“Cork”) negative pressure wound therapy (“NPWT”) devices and supplies and Sanara’s advanced wound care product line and associated services to new customers.

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) and Sanara MedTech Inc. (NASDAQSMTI) (“Sanara”) announced today the establishment of a partnership, SI Wound Care, LLC (“SI Wound Care”), focused on delivering a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction. The partnership is expected to enable InfuSystem to offer innovative products including Cork Medical LLC’s (“Cork”) negative pressure wound therapy (“NPWT”) devices and supplies and Sanara’s advanced wound care product line to new customers through the jointly controlled entity.

FORT WORTH, TX, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQSMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today details for the release of its results for the quarter ended September 30, 2022.

FORT WORTH, TX / ACCESSWIRE / November 12, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter ended September 30, 2021. Ron Nixon, Sanara's Executive Chairman, stated, "In the third

FORT WORTH, TX / ACCESSWIRE / November 9, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company") (NASDAQSMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced the commercial launch of two new innovative products from Cook Biotech Inc. Zach Fleming, Sanara's President, Surgical, stated, "A key component of our long-term

FORT WORTH, TX / ACCESSWIRE / October 28, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today details for the release of its results for the third quarter ended September 30, 2021. Sanara plans to issue its earnings release after

FORT WORTH, TX / ACCESSWIRE / September 22, 2021 / Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that the Company is scheduled to present virtually at the 2021 Cantor Virtual Global Healthcare Conference. Sanara's presentation will be given on

FORT WORTH, TX / ACCESSWIRE / August 26, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today it has been selected to present at the 6th annual MicroCap Leadership Summit on Friday, September 24, 2021. The MicroCap Leadership Summit is a two-day virtual

FORT WORTH, TX / ACCESSWIRE / August 16, 2021 / Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter ended June 30, 2021. Ron Nixon, Sanara's Executive Chairman, stated, "Sanara had another

FORT WORTH, TX / ACCESSWIRE / August 2, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today details for the release of its results for the second quarter ended June 30, 2021. Sanara plans to issue its earnings release after the market closes on

FORT WORTH, TX / ACCESSWIRE / July 19, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today the acquisition of certain assets of Rochal Industries, LLC ("Rochal"). Ron Nixon, Sanara's Executive Chairman, stated, "As part of our comprehensive wound and

FORT WORTH, TX / ACCESSWIRE / June 4, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today that it has closed an exclusive partnership with Pixalere Healthcare Inc. ("Pixalere"). Ron

FORT WORTH, TX / ACCESSWIRE / May 17, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQSMTI), a provider of surgical and chronic wound care products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter ended March 31, 2021. Ron Nixon,